The Valley Desk

NCT03093116 · Interventional trial

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Locally Advanced Solid Tumors, Metastatic Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov